scholarly journals O-0024 Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (AFFIRM)

2012 ◽  
Vol 23 ◽  
pp. iv16 ◽  
Author(s):  
Carles Pericay ◽  
Gunnar Folprecht ◽  
Mark Saunders ◽  
Anne Thomas ◽  
Jae Kyung Roh ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Line Treatment ◽  
Phase 2 ◽  
First Line ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Modified Folfox6 ◽  
First Line Treatment

A Phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3658-3658
Author(s):  
T. H. Cartwright ◽  
T. Lopez ◽  
S. J. Vukelja ◽  
C. Encarnacion ◽  
K. A. Boehm ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Line Treatment ◽  
First Line ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
First Line Treatment

Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer

2005 ◽  
Vol 5 (1) ◽  
pp. 50-56 ◽  
Author(s):  
Thomas Cartwright ◽  
Timothy Lopez ◽  
Svetislava J. Vukelja ◽  
Carlos Encarnacion ◽  
Kristi A. Boehm ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Line Treatment ◽  
First Line ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
First Line Treatment

A Phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3658-3658 ◽  
Author(s):  
T. H. Cartwright ◽  
T. Lopez ◽  
S. J. Vukelja ◽  
C. Encarnacion ◽  
K. A. Boehm ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Line Treatment ◽  
First Line ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
First Line Treatment

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

2014 ◽  
Vol 15 (10) ◽  
pp. 1065-1075 ◽  
Author(s):  
Volker Heinemann ◽  
Ludwig Fischer von Weikersthal ◽  
Thomas Decker ◽  
Alexander Kiani ◽  
Ursula Vehling-Kaiser ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Line Treatment ◽  
First Line ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
First Line Treatment

scholarly journals Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

2015 ◽  
Vol 51 (8) ◽  
pp. 942-949 ◽  
Author(s):  
Guillem Argilés ◽  
Mark P. Saunders ◽  
Fernando Rivera ◽  
Alberto Sobrero ◽  
Al Benson ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Line Treatment ◽  
First Line ◽  
Modified Folfox6 ◽  
First Line Treatment

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

2010 ◽  
Vol 11 (9) ◽  
pp. 845-852 ◽  
Author(s):  
Gianluca Masi ◽  
Fotios Loupakis ◽  
Lisa Salvatore ◽  
Lorenzo Fornaro ◽  
Chiara Cremolini ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Line Treatment ◽  
Phase 2 ◽  
First Line ◽  
Phase 2 Trial ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document